Superworth

Zai Lab profit margin ZLAB

Gross, operating and net profit as a share of revenue over the last twelve months, from 2024.

Net margin, 12 months
−41.9%
Operating margin, 12 months
−58.7%
Net margin on a year earlier
+7.8 pts
Peer median
15.6%

Over the twelve months to Jun 30, 2026, Zai Lab kept −41.9% of its revenue as net profit, with an operating margin of −58.7% and a gross margin of 56.5%.

The median for 10 large drugmakers of a similar size is 15.6%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−38.1%−49.9%58.6%
FY2024−64.4%−70.7%63.1%
FY2023n/an/a64.1%
FY2022n/an/a65.6%
FY2021n/an/a63.8%
FY2020n/an/a65.8%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−41.9%+7.8 pts−58.7%
Q1 FY26−39.3%+21.0 pts−53.5%
Q4 FY25−38.1%+26.3 pts−49.9%
Q3 FY25−46.8%+29.3 pts−51.6%
Q2 FY25−49.7%+42.8 pts−57.7%
Q1 FY25−60.3%n/a−64.1%
Q4 FY24−64.4%n/a−70.7%
Q3 FY24−76.1%n/a−95.1%
Q2 FY24−92.4%n/an/a
Q1 FY24n/an/an/a
Q4 FY23n/an/an/a
Q3 FY23n/an/an/a

Against its peers

Companies in Drug Manufacturers - General nearest Zai Lab's size, closest first, today.

CompanyProfit margin
ZLABZai Lab−41.9%
NRIXNurix Therapeutics42.0%
PBHPrestige Consumer Healthcare15.6%
HRMYHarmony Biosciences18.9%
OGNOrganon3.4%
LQDALiquidia30.7%
ARQTArcutis Biotherapeutics6.1%
INDVIndivior Pharmaceuticals26.7%
ANIPANI Pharmaceuticals11.1%
PAHCPhibro Animal Health6.6%
ANABAnaptysbion/m
Peer median15.6%

Where Zai Lab ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Zai Lab

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.